These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Characterisation of bovine lipopolysaccharide binding protein and the in vivo acute phase response to Pasteurella haemolytica Type A. Horadagoda NU, Eckersall PD, Andrew L, Gallay P, Heumann D, Gibbs HA. Vet Immunol Immunopathol; 1995 Nov; 49(1-2):61-74. PubMed ID: 8588345 [Abstract] [Full Text] [Related]
16. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Pugin J, Schürer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Proc Natl Acad Sci U S A; 1993 Apr 01; 90(7):2744-8. PubMed ID: 7681988 [Abstract] [Full Text] [Related]
17. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. Wurfel MM, Hailman E, Wright SD. J Exp Med; 1995 May 01; 181(5):1743-54. PubMed ID: 7536794 [Abstract] [Full Text] [Related]
20. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity. Theofan G, Horwitz AH, Williams RE, Liu PS, Chan I, Birr C, Carroll SF, Mészáros K, Parent JB, Kasler H. J Immunol; 1994 Apr 01; 152(7):3623-9. PubMed ID: 7511654 [Abstract] [Full Text] [Related] Page: [Next] [New Search]